T-cell responses directed against the receptor-binding domain of the SARS-CoV-2 spike protein were associated with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer, with lower T-cell responses observed in patients with blood cancers, according to a new study.
Click here for original story, T-cell responses may help predict protection against SARS-CoV-2 infection in individuals with and without cancer
Source: ScienceDaily